U.S. flag

An official website of the United States government

NM_005957.5(MTHFR):c.1262G>C (p.Trp421Ser) AND Homocystinuria due to methylene tetrahydrofolate reductase deficiency

Germline classification:
Likely pathogenic (3 submissions)
Last evaluated:
Aug 6, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000167612.7

Allele description [Variation Report for NM_005957.5(MTHFR):c.1262G>C (p.Trp421Ser)]

NM_005957.5(MTHFR):c.1262G>C (p.Trp421Ser)

Gene:
MTHFR:methylenetetrahydrofolate reductase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_005957.5(MTHFR):c.1262G>C (p.Trp421Ser)
HGVS:
  • NC_000001.11:g.11794443C>G
  • NG_013351.1:g.16661G>C
  • NM_001330358.2:c.1385G>C
  • NM_005957.5:c.1262G>CMANE SELECT
  • NP_001317287.1:p.Trp462Ser
  • NP_005948.3:p.Trp421Ser
  • NP_005948.3:p.Trp421Ser
  • LRG_726t1:c.1262G>C
  • LRG_726:g.16661G>C
  • LRG_726p1:p.Trp421Ser
  • NC_000001.10:g.11854500C>G
  • NM_005957.4:c.1262G>C
  • P42898:p.Trp421Ser
Protein change:
W421S
Links:
UniProtKB: P42898#VAR_074143; dbSNP: rs200137991
NCBI 1000 Genomes Browser:
rs200137991
Molecular consequence:
  • NM_001330358.2:c.1385G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005957.5:c.1262G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Homocystinuria due to methylene tetrahydrofolate reductase deficiency
Synonyms:
HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY; Homocysteinemia due to MTHFR deficiency; Homocysteinemia due to methylenetetrahydro-folate reductase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009353; MedGen: C1856061; Orphanet: 395; OMIM: 236250

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000218493University Children's Hospital, University of Zurich
no assertion criteria provided

(Clinical disease; enzymatic activity/kinetics in patient fibroblasts)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001574682Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Aug 6, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV002094633Natera, Inc.
no assertion criteria provided
Likely pathogenic
(Sep 7, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Functional characterization of missense mutations in severe methylenetetrahydrofolate reductase deficiency using a human expression system.

Burda P, Suormala T, Heuberger D, Schäfer A, Fowler B, Froese DS, Baumgartner MR.

J Inherit Metab Dis. 2017 Mar;40(2):297-306. doi: 10.1007/s10545-016-9987-0. Epub 2016 Oct 14.

PubMed [citation]
PMID:
27743313

Insights into severe 5,10-methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients.

Burda P, Schäfer A, Suormala T, Rummel T, Bürer C, Heuberger D, Frapolli M, Giunta C, Sokolová J, Vlášková H, Kožich V, Koch HG, Fowler B, Froese DS, Baumgartner MR.

Hum Mutat. 2015 Jun;36(6):611-21. doi: 10.1002/humu.22779. Epub 2015 Apr 27.

PubMed [citation]
PMID:
25736335
See all PubMed Citations (4)

Details of each submission

From University Children's Hospital, University of Zurich, SCV000218493.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001574682.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Experimental studies have shown that this missense change affects MTHFR function (PMID: 27743313). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MTHFR protein function. ClinVar contains an entry for this variant (Variation ID: 187892). This missense change has been observed in individual(s) with severe methylenetetrahydrofolate reductase deficiency (PMID: 25736335, 31069529). This variant is present in population databases (rs200137991, gnomAD 0.0009%). This sequence change replaces tryptophan, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 421 of the MTHFR protein (p.Trp421Ser). This variant disrupts the p.Trp421 amino acid residue in MTHFR. Other variant(s) that disrupt this residue have been observed in individuals with MTHFR-related conditions (Invitae), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002094633.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024